Cargando…

RASSF1A and SIRT6 in non-small cell lung cancer: Relationship with clinical outcome

This study investigated the expression of RASSF1A and SIRT6 in non-small cell lung cancer (NSCLC) and its relationship with clinical prognosis. The expression in 122 cases of NSCLC tissues (NSCLC group) and 122 cases of normal lung tissues (NOR group) during the same period were detected by immunohi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Tao, Sun, Zhaojun, Liu, Fengling, Wang, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707562/ https://www.ncbi.nlm.nih.gov/pubmed/29204192 http://dx.doi.org/10.3892/ol.2017.6172

Ejemplares similares

RASSF6; the Putative Tumor Suppressor of the RASSF Family
por: Iwasa, Hiroaki, et al.
Publicado: (2015)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

The coiled-coil domain of oncogene RASSF 7 inhibits hippo signaling and promotes non-small cell lung cancer
por: Zheng, Xiaoying, et al.
Publicado: (2017)

The Expression and Related Clinical Significance of SIRT3 in Non-Small-Cell Lung Cancer
por: Yang, Guo-Cai, et al.
Publicado: (2017)

Regulation of RASSF by non-coding RNAs in different cancers: RASSFs as masterminds of their own destiny as tumor suppressors and oncogenes
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2022)

RASSF1A Regulates Spindle Organization by Modulating Tubulin Acetylation via SIRT2 and HDAC6 in Mouse Oocytes
por: Jeon, Hyuk-Joon, et al.
Publicado: (2020)

Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer
por: Zhu, Bojin, et al.
Publicado: (2018)

RASSF1 Polymorphisms in Cancer
por: Gordon, Marilyn, et al.
Publicado: (2012)

The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
por: Hesson, Luke B, et al.
Publicado: (2009)

The RASSF1 Gene and the Opposing Effects of the RASSF1A and RASSF1C Isoforms on Cell Proliferation and Apoptosis
por: Reeves, Mark E., et al.
Publicado: (2013)

Emerging role of SIRT2 in non-small cell lung cancer
por: Zheng, Mengge, et al.
Publicado: (2021)

Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome
por: Xu, Jia, et al.
Publicado: (2012)

RASSF Family Proteins
por: Clark, Geoffrey J., et al.
Publicado: (2012)

Association of promoter methylation of RASSF1A and KRAS mutations in non-small cell lung carcinoma in Kashmiri population (India)
por: Din Shah, Naseer Ue, et al.
Publicado: (2020)

RASSF6 Expression in Adipocytes Is Down-Regulated by Interaction with Macrophages
por: Sanada, Yohei, et al.
Publicado: (2013)

Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer
por: Meng, Wei, et al.
Publicado: (2012)

RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1
por: Volodko, Natalia, et al.
Publicado: (2016)

Correlation Between RASSF1A Gene Promoter Hypermethylation in Serum or Sputum and Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis
por: Zhang, Zhen, et al.
Publicado: (2019)

The Role of RASSF1A Methylation in Cancer
por: Hesson, Luke B., et al.
Publicado: (2007)

RASSF6 downregulation promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal cancer
por: Zhou, Rui, et al.
Publicado: (2017)

Loss of RASSF2 Enhances Tumorigencity of Lung Cancer Cells and Confers Resistance to Chemotherapy
por: Clark, Jennifer, et al.
Publicado: (2012)

Circ_0078767 suppresses non‐small‐cell lung cancer by protecting RASSF1A expression via sponging miR‐330‐3p
por: Chen, Ting, et al.
Publicado: (2018)

The correlation of serum sirt6 with clinical outcome and prognosis in patients with gastric cancer
por: Li, Danyang, et al.
Publicado: (2022)

RASSF1A and the Taxol Response in Ovarian Cancer
por: Kassler, Susannah, et al.
Publicado: (2012)

Effect of DNA methylation inhibitor on RASSF1A genes expression in non-small cell lung cancer cell line A549 and A549DDP
por: Mengxi, Duan, et al.
Publicado: (2013)

Clinical utility of RASSF1A methylation in human malignancies
por: Grawenda, A M, et al.
Publicado: (2015)

Promoter Methylation of CDKN2A, RARβ, and RASSF1A in Non-Small Cell Lung Carcinoma: Quantitative Evaluation Using Pyrosequencing
por: Lee, Jung Uee, et al.
Publicado: (2012)

Identification and characterization of RASSF1C piRNA target genes in lung cancer cells
por: Reeves, Mark E, et al.
Publicado: (2017)

RASSF1A controls tissue stiffness and cancer stem‐like cells in lung adenocarcinoma
por: Pankova, Daniela, et al.
Publicado: (2019)

The loss-of-function of DNA methyltransferase 1 by siRNA impairs the growth of non-small cell lung cancer with alleviated side effects via reactivation of RASSF1A and APC in vitro and vivo
por: Lai, Qi, et al.
Publicado: (2017)

Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA)
por: Zhan, Leyun, et al.
Publicado: (2017)

The relationship between weight loss and interleukin 6 in non-small-cell lung cancer.
por: Scott, H. R., et al.
Publicado: (1996)

Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathway
por: Bai, Lihong, et al.
Publicado: (2016)

Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer
por: Senchenko, Vera N, et al.
Publicado: (2010)

SIRT6 drives epithelial-to-mesenchymal transition and metastasis in non-small cell lung cancer via snail-dependent transrepression of KLF4
por: Li, Ziming, et al.
Publicado: (2018)

Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers
por: Riffet, Marc, et al.
Publicado: (2021)

Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer
por: Shin, Dong Hoon, et al.
Publicado: (2023)

RASSF1A and the rs2073498 Cancer Associated SNP
por: Donninger, Howard, et al.
Publicado: (2011)

Methylation Dynamics of RASSF1A and Its Impact on Cancer
por: Malpeli, Giorgio, et al.
Publicado: (2019)

Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors
por: Malpeli, Giorgio, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0jgin4jkp976c89n0bcv730cpp